| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/20/2005 | US20050233418 Cytokine polypeptides |
| 10/20/2005 | US20050233417 Growth hormone variations in humans and their uses |
| 10/20/2005 | US20050233416 Mutant protein with insertion, deletion, or replacement; lysine production; gene expression |
| 10/20/2005 | US20050233415 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free |
| 10/20/2005 | US20050233414 Comprises nucleotide sequences coding protein which are involved in the biosynthesis of oligosaccharide antibiotics and bactericides; bioreactors for human medicines |
| 10/20/2005 | US20050233408 Modified bacterial surface layer proteins |
| 10/20/2005 | US20050233402 Heparinase III HLGAG fragments and uses thereof |
| 10/20/2005 | US20050233396 an assay method of infecting cultured cells with vaccinia virus;co-transfecting the cells with plasmids of DNA encoding the I7L protease enzyme such that both the substrate protein and enzyme are expressed; then measuring cleaved I7L protease |
| 10/20/2005 | US20050233385 Using antibodies on cell surfaces |
| 10/20/2005 | US20050233381 Libraries of oligonucleotides created by genetic engineering |
| 10/20/2005 | US20050233379 Methods of antagonizing morphogens |
| 10/20/2005 | US20050233374 Reagents and methods useful for detecting diseases of the prostate |
| 10/20/2005 | US20050233372 Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight |
| 10/20/2005 | US20050233371 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/20/2005 | US20050233369 Biosynthetic gene cluster for jerangolids |
| 10/20/2005 | US20050233367 Device for extracting biological molecules from tissue specimens and methods for preparing the same |
| 10/20/2005 | US20050233365 Method for producing plasmid DNA on a manufacturing scale |
| 10/20/2005 | US20050233364 Rapid integration site mapping |
| 10/20/2005 | US20050233362 Method for collecting purified cells |
| 10/20/2005 | US20050233361 PPARdelta assay |
| 10/20/2005 | US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 10/20/2005 | US20050233355 Human cDNAs encoding polypeptides having kinase functions |
| 10/20/2005 | US20050233350 Method for typing of minor histocompatibility antigen HA-1 |
| 10/20/2005 | US20050233348 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells |
| 10/20/2005 | US20050233346 Plant promoters and methods of use thereof |
| 10/20/2005 | US20050233345 Primers for detecting food poisoning bacteria and a use thereof |
| 10/20/2005 | US20050233344 RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA) |
| 10/20/2005 | US20050233343 Composition of matter comprising library of analytes hybridized to nucleic acid array for generating complex formation and signaling domains |
| 10/20/2005 | US20050233342 Methods of preventing off-target gene silencing |
| 10/20/2005 | US20050233336 Compositions and methods for producing libraries with controlled compositions and screening probabilities |
| 10/20/2005 | US20050233333 Reagents and methods for isolation of purified RNA |
| 10/20/2005 | US20050233332 Multiple fluorophore detector system |
| 10/20/2005 | US20050233328 Methods of identifying compounds that modulate protein activity |
| 10/20/2005 | US20050233326 Drug screening for binding property or signal transduction between a G protein-coupled receptor and humanin or a salt; Alzheimer*s disease |
| 10/20/2005 | US20050233323 Novel protein and dna thereof |
| 10/20/2005 | US20050233322 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle) |
| 10/20/2005 | US20050233317 Modulate aptamer and method of detecting target protein by using the same |
| 10/20/2005 | US20050233315 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 10/20/2005 | US20050233313 Methods and reagents for identifying inhibitors of viral protease activity |
| 10/20/2005 | US20050233311 Family of picornaviruses |
| 10/20/2005 | US20050233308 Method for modifying a property of a protein |
| 10/20/2005 | US20050233306 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 10/20/2005 | US20050233305 Sugar chain library constructed via cargo receptor gene modification |
| 10/20/2005 | US20050233304 Method of screening remedy for renal failure |
| 10/20/2005 | US20050232950 Viruses comprising mutant ion channel protein |
| 10/20/2005 | US20050232949 transgenic edible plants comprising a nucleotide construct, including promoters that preferentially targets expression to an edible tissue of the plant and untranslated signal sequences, that codes an immunogen of a recombinant animal viral antigen protein, that induces an immune responses |
| 10/20/2005 | US20050232947 Bacterial spores |
| 10/20/2005 | US20050232946 Vaccine against microbial pathogens |
| 10/20/2005 | US20050232942 Virulence genes, proteins, and their use |
| 10/20/2005 | US20050232940 Recombinant plasmid and a method of controlling the effects of yersinia pestis |
| 10/20/2005 | US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection |
| 10/20/2005 | US20050232937 Paramycobacterial diagnostics and vaccines |
| 10/20/2005 | US20050232936 Meningococcus adhesins nada, app and orf 40 |
| 10/20/2005 | US20050232934 Recombinant reverse transcriptases |
| 10/20/2005 | US20050232933 CMV-IE1 peptides and method of use |
| 10/20/2005 | US20050232932 Compositions and methods for dendritic cell-based immunotherapy |
| 10/20/2005 | US20050232926 Expressed in melanoma, breast cancer and hepatocellular carcinoma; fab fragments; fv fragments; competitive binding; for inducing caspase mediated apoptosis; neoplasm diagnosis |
| 10/20/2005 | US20050232919 Monoclonal antibodies that specifically block biological activity of a tumor antigen |
| 10/20/2005 | US20050232918 Differentially expressed genes associated with obesity and type 2 diabetes |
| 10/20/2005 | US20050232914 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof |
| 10/20/2005 | US20050232913 Short chain neurotoxin from sea snake-lapemis hardwickii and genes encoding the neurotoxin |
| 10/20/2005 | US20050232910 Comprises sakacine G polypeptide for preventing bacterial propagation during food processing; potentially valuable for preserving fermented food products in terms of quality and health |
| 10/20/2005 | US20050232907 Use of herpes vectors for tumor therapy |
| 10/20/2005 | US20050232906 Adjuvant preparation for the induction of specific immunity |
| 10/20/2005 | US20050232901 Materials and methods for treating or preventing oxalate-related disease |
| 10/20/2005 | US20050232900 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 10/20/2005 | CA2799469A1 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 10/20/2005 | CA2590604A1 Microrna encoded by ebv, kshv and hcmv and microrna for targeting the same |
| 10/20/2005 | CA2563887A1 Mite allergen zen 1 |
| 10/20/2005 | CA2563513A1 Remedy for neurodegenerative diseases |
| 10/20/2005 | CA2563427A1 Pufa-pks genes from ulkenia |
| 10/20/2005 | CA2563173A1 Methods for producing hyaluronic acid in a bacillus cell |
| 10/20/2005 | CA2562780A1 Nucleic acid melting analysis with saturation dyes |
| 10/20/2005 | CA2561947A1 Preventives/remedies for cancer |
| 10/20/2005 | CA2561809A1 Bmp-7 variants with improved properties |
| 10/20/2005 | CA2561593A1 Antiobesity drug |
| 10/20/2005 | CA2561276A1 Irta-5 antibodies and their uses |
| 10/20/2005 | CA2561221A1 Rna interference modulators of hedgehog signaling and uses thereof |
| 10/20/2005 | CA2561163A1 Stabilised tat antigen and the use thereof for anti-hiv vaccination |
| 10/20/2005 | CA2560937A1 Compositions and methods for inducing anti-tumor immunity |
| 10/20/2005 | CA2560655A1 Method for improving plants |
| 10/20/2005 | CA2560504A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 10/20/2005 | CA2558870A1 Process for the production of fine chemicals |
| 10/20/2005 | CA2558603A1 Self-processing plants and plant parts |
| 10/20/2005 | CA2558044A1 Inducible promoters from the ni16 gene of arabidopsis |
| 10/20/2005 | CA2555390A1 Immunostimulatory viral rna oligonucleotides |
| 10/20/2005 | CA2465396A1 Rapid integration site mapping |
| 10/19/2005 | EP1587016A1 Method of identifying disease-sensitivity gene and program and system to be used therefor |
| 10/19/2005 | EP1586662A1 Nucleic acid detection method using multiple pairs of donor flurophores and quencher molecules in the same probe |
| 10/19/2005 | EP1586657A1 Method of diagnosing depression |
| 10/19/2005 | EP1586655A2 Improved methods for transfecting T cells |
| 10/19/2005 | EP1586654A1 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 10/19/2005 | EP1586653A1 Noc2 knockout mouse |
| 10/19/2005 | EP1586652A1 Genes and uses for plant improvement |
| 10/19/2005 | EP1586651A1 Means and method for modifying the biomass of plants |
| 10/19/2005 | EP1586650A1 Intervention in the energy metabolism of eukaryotic cells for selection and increase of expression |
| 10/19/2005 | EP1586649A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 10/19/2005 | EP1586648A1 Juvenile hormone transmethylase genes and method of using the same |
| 10/19/2005 | EP1586647A1 Process for the biological production of 1,3-propanediol with high titer |
| 10/19/2005 | EP1586646A2 Lawsonia intracellularis vaccine |